Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor

Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor

US Patent 11224573 · Granted Jan 18, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune ch2024
Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune ch2024
Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune ch2024
Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune ch2023
Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune ch2023
Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune ch2023
Cross-linked polymer modified nanoparticles2022
Cross-linked polymer modified nanoparticles2022
Immunotherapeutic constructs and methods of their use2022
Immunotherapeutic constructs and methods of their use2022
Immunotherapeutic constructs and methods of their use2022
Cross-linked polymer modified nanoparticles2021